Innovative Strategies in Cancer Treatment: Harnessing Cuproptosis and Nanotechnology for Targeted Therapy

•Cuproptosis unveiled has emerged as a promising approach in tumor eradication.•Nanoparticles triggering cuproptosis could significantly impact cancer treatment.•Nanoparticles triggering cuproptosis offer a promising personalized cancer therapy.

Saved in:
Bibliographic Details
Published inDrug discovery today Vol. 29; no. 10; p. 104104
Main Authors Dongsar, Tenzin Tsering, Dongsar, Tenzin Sonam, Gupta, Garima, Kesharwani, Prashant
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.10.2024
Online AccessGet full text

Cover

Abstract •Cuproptosis unveiled has emerged as a promising approach in tumor eradication.•Nanoparticles triggering cuproptosis could significantly impact cancer treatment.•Nanoparticles triggering cuproptosis offer a promising personalized cancer therapy.
AbstractList •Cuproptosis unveiled has emerged as a promising approach in tumor eradication.•Nanoparticles triggering cuproptosis could significantly impact cancer treatment.•Nanoparticles triggering cuproptosis offer a promising personalized cancer therapy.
ArticleNumber 104104
Author Kesharwani, Prashant
Gupta, Garima
Dongsar, Tenzin Sonam
Dongsar, Tenzin Tsering
Author_xml – sequence: 1
  givenname: Tenzin Tsering
  surname: Dongsar
  fullname: Dongsar, Tenzin Tsering
– sequence: 2
  givenname: Tenzin Sonam
  surname: Dongsar
  fullname: Dongsar, Tenzin Sonam
– sequence: 3
  givenname: Garima
  surname: Gupta
  fullname: Gupta, Garima
  organization: Graphic Era Hill University, Dehradun 248002, India
– sequence: 4
  givenname: Prashant
  surname: Kesharwani
  fullname: Kesharwani, Prashant
  email: prashantdops@gmail.com
  organization: Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi 110062, India
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39029867$$D View this record in MEDLINE/PubMed
BookMark eNp9kE2LFDEQhoOsuB_6D0Ry9NJjOh-dtAdBBnUXFj04nkN1uno2w0wyJumB-fdm6XWPCwVVFO9bH881uQgxICHvW7ZqWdt92q3GNI8-rzjjsrZkjVfkqjXaNMoIflFrofqmk7K7JNc57xhrea-6N-RS9Iz3ptNXxN-FEE9Q_Anp75Kg4NZjpj7QNQSHiW4SQjlgKJ_pLaSAOfuwpev5mOKxxOwzhTDSnxBiQfcQ4j5uz3SK1QhpiwVHunnABMfzW_J6gn3Gd0_5hvz5_m2zvm3uf_24W3-9bxyXbWkG3QMo47RjvJPT5EQLfHDGuUGDUsDUBEKoTg9CO8W6QSvD5cQmiaMBycQN-bjMrRf-nTEXe_DZ4X4PAeOcrWCGGyF131epXKQuxZwTTvaY_AHS2bbMPkK2O7tAto-Q7QK52j48bZiHA47Ppv9Uq-DLIsD658ljstl5rDhHn9AVO0b_8oZ_uh6TEA
Cites_doi 10.1002/wnan.1797
10.1039/D2TB01150F
10.1002/smll.202205354
10.1016/j.molcel.2022.05.001
10.1016/j.ijpharm.2023.123025
10.3390/nano12193312
10.1002/adma.202204733
10.1016/j.jinorgbio.2021.111634
ContentType Journal Article
Copyright 2024 Elsevier Ltd
Copyright_xml – notice: 2024 Elsevier Ltd
DBID NPM
AAYXX
CITATION
7X8
DOI 10.1016/j.drudis.2024.104104
DatabaseName PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle PubMed
CrossRef
MEDLINE - Academic
DatabaseTitleList
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Engineering
Pharmacy, Therapeutics, & Pharmacology
EISSN 1878-5832
ExternalDocumentID 10_1016_j_drudis_2024_104104
39029867
S1359644624002290
Genre Editorial
Commentary
GroupedDBID ---
--K
--M
.~1
0R~
1B1
1RT
1~.
1~5
29G
4.4
457
4G.
53G
5GY
5VS
7-5
71M
8P~
AABNK
AACTN
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AAXKI
AAXUO
AAYOK
ABFNM
ABFRF
ABGSF
ABJNI
ABMAC
ABOCM
ABUDA
ABXDB
ABZDS
ACDAQ
ACGFO
ACGFS
ACRLP
ADBBV
ADEZE
ADMUD
ADUVX
AEBSH
AEFWE
AEHWI
AEKER
AENEX
AFJKZ
AFKWA
AFTJW
AFXIZ
AGHFR
AGRDE
AGUBO
AGYEJ
AIEXJ
AIKHN
AITUG
AJOXV
AKRWK
ALCLG
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
CS3
DU5
EBS
EFJIC
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-Q
GBLVA
HVGLF
HZ~
IH2
IHE
J1W
KOM
M41
MO0
N9A
O-L
O9-
OAUVE
OGGZJ
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SCC
SDF
SDG
SES
SEW
SPCBC
SSP
SSU
SSZ
T5K
~G-
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c241t-b79aa58c7c0264ffc31a2bc8ccb7a55a05fa33567b37c506b75824f0f4ed8a403
IEDL.DBID .~1
ISSN 1359-6446
1878-5832
IngestDate Sat Aug 17 04:24:23 EDT 2024
Wed Oct 09 16:47:08 EDT 2024
Wed Oct 09 10:34:12 EDT 2024
Sat Sep 21 16:01:55 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 10
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c241t-b79aa58c7c0264ffc31a2bc8ccb7a55a05fa33567b37c506b75824f0f4ed8a403
Notes SourceType-Scholarly Journals-1
content type line 23
ObjectType-Editorial-2
ObjectType-Commentary-1
PMID 39029867
PQID 3082834799
PQPubID 23479
ParticipantIDs proquest_miscellaneous_3082834799
crossref_primary_10_1016_j_drudis_2024_104104
pubmed_primary_39029867
elsevier_sciencedirect_doi_10_1016_j_drudis_2024_104104
PublicationCentury 2000
PublicationDate 2024-10-01
PublicationDateYYYYMMDD 2024-10-01
PublicationDate_xml – month: 10
  year: 2024
  text: 2024-10-01
  day: 01
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Drug discovery today
PublicationTitleAlternate Drug Discov Today
PublicationYear 2024
Publisher Elsevier Ltd
Publisher_xml – name: Elsevier Ltd
References Zhang, Zeng, Wu, Liu, Zhang, Song (b0020) 2022; 13
Zhou (b0040) 2023; 62
Xu (b0045) 2022; 34
Lu, Pan, Gao, Pu, He (b0030) 2022; 10
da Silva (b0010) 2022; 226
Zhong, Dai, Wang, Wang, Qian, Wang (b0015) 2022; 14
Vincent, Lau, Evyan, Chin, Sillanpää, Chia (b0025) 2022; 12
Zhang (b0035) 2023; 640
Cobine, Brady (b0005) 2022; 82
Jia (b0050) 2023; 19
Zhou (10.1016/j.drudis.2024.104104_b0040) 2023; 62
da Silva (10.1016/j.drudis.2024.104104_b0010) 2022; 226
Zhang (10.1016/j.drudis.2024.104104_b0020) 2022; 13
Zhong (10.1016/j.drudis.2024.104104_b0015) 2022; 14
Vincent (10.1016/j.drudis.2024.104104_b0025) 2022; 12
Xu (10.1016/j.drudis.2024.104104_b0045) 2022; 34
Lu (10.1016/j.drudis.2024.104104_b0030) 2022; 10
Cobine (10.1016/j.drudis.2024.104104_b0005) 2022; 82
Zhang (10.1016/j.drudis.2024.104104_b0035) 2023; 640
Jia (10.1016/j.drudis.2024.104104_b0050) 2023; 19
References_xml – volume: 62
  year: 2023
  ident: b0040
  article-title: Photothermally triggered copper payload release for cuproptosis-promoted cancer synergistic therapy
  publication-title: Angew Chem Int Ed Engl
  contributor:
    fullname: Zhou
– volume: 13
  year: 2022
  ident: b0020
  article-title: Cuproptosis-related risk score predicts prognosis and characterizes the tumor microenvironment in hepatocellular carcinoma
  publication-title: Front Immunol
  contributor:
    fullname: Song
– volume: 82
  start-page: 1786
  year: 2022
  end-page: 1787
  ident: b0005
  article-title: Cuproptosis: Cellular and molecular mechanisms underlying copper induced cell death
  publication-title: Mol Cell
  contributor:
    fullname: Brady
– volume: 34
  start-page: 2204733
  year: 2022
  ident: b0045
  article-title: An enzyme-engineered nonporous copper(I) coordination polymer nanoplatform for cuproptosis-based synergistic cancer therapy
  publication-title: Adv Mater
  contributor:
    fullname: Xu
– volume: 19
  year: 2023
  ident: b0050
  article-title: Brain-targeted HFn-Cu-REGO nanoplatform for site-specific delivery and manipulation of autophagy and cuproptosis in glioblastoma
  publication-title: Small
  contributor:
    fullname: Jia
– volume: 10
  start-page: 6296
  year: 2022
  end-page: 6306
  ident: b0030
  article-title: Reversal of cisplatin chemotherapy resistance by glutathione-resistant copper-based nanomedicine via cuproptosis
  publication-title: J Mater Chem B
  contributor:
    fullname: He
– volume: 640
  year: 2023
  ident: b0035
  article-title: Syphilis mimetic nanoparticles for cuproptosis-based synergistic cancer therapy via reprogramming copper metabolism
  publication-title: Int J Pharm
  contributor:
    fullname: Zhang
– volume: 226
  year: 2022
  ident: b0010
  article-title: Copper in tumors and the use of copper-based compounds in cancer treatment
  publication-title: J Inorg Biochem
  contributor:
    fullname: da Silva
– volume: 14
  year: 2022
  ident: b0015
  article-title: Copper-based nanomaterials for cancer theranostics
  publication-title: Wiley Interdiscip Rev Nanomed Nanobiotechnol
  contributor:
    fullname: Wang
– volume: 12
  year: 2022
  ident: b0025
  article-title: Biogenic synthesis of copper-based nanomaterials using plant extracts and their applications: Current and future directions
  publication-title: Nanomaterials (Basel)
  contributor:
    fullname: Chia
– volume: 13
  year: 2022
  ident: 10.1016/j.drudis.2024.104104_b0020
  article-title: Cuproptosis-related risk score predicts prognosis and characterizes the tumor microenvironment in hepatocellular carcinoma
  publication-title: Front Immunol
  contributor:
    fullname: Zhang
– volume: 14
  year: 2022
  ident: 10.1016/j.drudis.2024.104104_b0015
  article-title: Copper-based nanomaterials for cancer theranostics
  publication-title: Wiley Interdiscip Rev Nanomed Nanobiotechnol
  doi: 10.1002/wnan.1797
  contributor:
    fullname: Zhong
– volume: 10
  start-page: 6296
  year: 2022
  ident: 10.1016/j.drudis.2024.104104_b0030
  article-title: Reversal of cisplatin chemotherapy resistance by glutathione-resistant copper-based nanomedicine via cuproptosis
  publication-title: J Mater Chem B
  doi: 10.1039/D2TB01150F
  contributor:
    fullname: Lu
– volume: 19
  year: 2023
  ident: 10.1016/j.drudis.2024.104104_b0050
  article-title: Brain-targeted HFn-Cu-REGO nanoplatform for site-specific delivery and manipulation of autophagy and cuproptosis in glioblastoma
  publication-title: Small
  doi: 10.1002/smll.202205354
  contributor:
    fullname: Jia
– volume: 82
  start-page: 1786
  year: 2022
  ident: 10.1016/j.drudis.2024.104104_b0005
  article-title: Cuproptosis: Cellular and molecular mechanisms underlying copper induced cell death
  publication-title: Mol Cell
  doi: 10.1016/j.molcel.2022.05.001
  contributor:
    fullname: Cobine
– volume: 640
  year: 2023
  ident: 10.1016/j.drudis.2024.104104_b0035
  article-title: Syphilis mimetic nanoparticles for cuproptosis-based synergistic cancer therapy via reprogramming copper metabolism
  publication-title: Int J Pharm
  doi: 10.1016/j.ijpharm.2023.123025
  contributor:
    fullname: Zhang
– volume: 62
  year: 2023
  ident: 10.1016/j.drudis.2024.104104_b0040
  article-title: Photothermally triggered copper payload release for cuproptosis-promoted cancer synergistic therapy
  publication-title: Angew Chem Int Ed Engl
  contributor:
    fullname: Zhou
– volume: 12
  year: 2022
  ident: 10.1016/j.drudis.2024.104104_b0025
  article-title: Biogenic synthesis of copper-based nanomaterials using plant extracts and their applications: Current and future directions
  publication-title: Nanomaterials (Basel)
  doi: 10.3390/nano12193312
  contributor:
    fullname: Vincent
– volume: 34
  start-page: 2204733
  year: 2022
  ident: 10.1016/j.drudis.2024.104104_b0045
  article-title: An enzyme-engineered nonporous copper(I) coordination polymer nanoplatform for cuproptosis-based synergistic cancer therapy
  publication-title: Adv Mater
  doi: 10.1002/adma.202204733
  contributor:
    fullname: Xu
– volume: 226
  year: 2022
  ident: 10.1016/j.drudis.2024.104104_b0010
  article-title: Copper in tumors and the use of copper-based compounds in cancer treatment
  publication-title: J Inorg Biochem
  doi: 10.1016/j.jinorgbio.2021.111634
  contributor:
    fullname: da Silva
SSID ssj0012956
Score 2.5016928
Snippet •Cuproptosis unveiled has emerged as a promising approach in tumor eradication.•Nanoparticles triggering cuproptosis could significantly impact cancer...
SourceID proquest
crossref
pubmed
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 104104
Title Innovative Strategies in Cancer Treatment: Harnessing Cuproptosis and Nanotechnology for Targeted Therapy
URI https://dx.doi.org/10.1016/j.drudis.2024.104104
https://www.ncbi.nlm.nih.gov/pubmed/39029867
https://www.proquest.com/docview/3082834799/abstract/
Volume 29
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB5CekkPpU362D6CCiWnqGuvJUvqLSwNm4aGQDeQm9DL4B68y9pb2Et-e0Z-bBJICeRoYyOhGc83sr75BuCb9YUocqloSHNDEfEZNSJRVDrJvJQqDW3rhN8X-eyK_brm1zswHWphIq2yj_1dTG-jdX9n3K_meFmW4z9pxhWieR5ZkFG1PFawIxihT3-_2dI8EM7aDq7xYRqfHsrnWo6XX619GUW7JywedqZ9u7ZH4Ol_6WcLQ6ev4VWfP5KTbopvYCdU-_DynqrgPhxddnLUm2Myv6uuqo_JEbm8E6reHEB51rdE_RfIoFIbalJWZBp9YUXmAwv9B5mZVQyKOACZrnGWy2ZRlzUxlScYoBfN9g89wSyYzFt-efD9BDZv4er053w6o33rBeoQ0htqhTKGSycc7tFYUbgsNRPrpHNWGM5NwguTZTwXNhOOJ7nFbceEFUnBgpeGJdk72K0WVfgAxLYqb27ilXcM8w1plDcp49ZhaClUPgI6rLhedgobeqCe_dWdhXS0kO4sNAIxmEU_8BSNIPDEm18HK2r8iOLJiKnCYl3rqNkjY02tGsH7zrzbuWQqqtTn4uOzx_0Ee_GqowB-ht1mtQ5fMJVp7GHrq4fw4uTsfHZxC5UU9CQ
link.rule.ids 315,786,790,4521,24144,27957,27958,45620,45714
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB7SzaHtobTpa9OXCiWnmPVDsqTewtLgbZIlUAdyE3oZnIN3WXsL--8j2fKmhZZCr7aFBo00M_J88w3AF2UqWuWMRzbJZeQ8Po4kjXnENMOGMZ7YvnXC1TIvbvD3W3J7APOxFsbDKoPtH2x6b63Dk1lYzdm6rmc_koxw581zj4L0rOWP4BATmuAJHJ4tLorlPpmQ8r6Jq_8-8gPGCroe5mU2W1N73u4U-3xnEjq2_cFD_S0C7T3R-XN4FkJIdDZI-QIObHMET38hFjyCk-uBkXp3isqHAqv2FJ2g6weu6t1LqBehK-pPi0aiWtuiukFzvx02qByB6F9RITfeLroJ0HzrpFx3q7ZukWwMcjZ61e1_0iMXCKOyh5hbEwTYvYKb82_lvIhC94VIO6_eRYpyKQnTVLtrGq4qnSUyVZppragkRMakkllGcqoyqkmcK3fzSHEVV9gaJnGcvYZJs2rsW0CqJ3rTqeFGYxdyMMmNTDBR2lmXiudTiMYVF-uBZEOM6LM7MWhIeA2JQUNToKNaxG-bRTg_8I-Rn0ctCneOfHJENna1bYWn7WG-rJZP4c2g3r0sGfdE9Tk9_u95P8Hjory6FJeL5cU7eOLfDIjA9zDpNlv7wUU2nfoYdu49_f322g
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Innovative+Strategies+in+Cancer+Treatment%3A+Harnessing+Cuproptosis+and+Nanotechnology+for+Targeted+Therapy&rft.jtitle=Drug+discovery+today&rft.au=Dongsar%2C+Tenzin+Tsering&rft.au=Dongsar%2C+Tenzin+Sonam&rft.au=Gupta%2C+Garima&rft.au=Kesharwani%2C+Prashant&rft.date=2024-10-01&rft.issn=1359-6446&rft.volume=29&rft.issue=10&rft.spage=104104&rft_id=info:doi/10.1016%2Fj.drudis.2024.104104&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_drudis_2024_104104
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1359-6446&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1359-6446&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1359-6446&client=summon